322
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Additive effects of dietary glycotoxins and androgen excess on the kidney of a female rat modelFootnoteFootnote

, , , , , , , , & show all
Pages 159-168 | Received 09 Apr 2015, Accepted 09 Jul 2015, Published online: 17 May 2019

References

  • T.NiwaMass spectrometry for the study of protein glycation in diseaseMass Spectrom Rev252006713723
  • R.D.SembaE.J.NicklettL.FerrucciDoes accumulation of advanced glycation end products contribute to the aging phenotype?J Gerontol A Biol Sci Med Sci652010963975
  • S.Y.GohM.E.CooperClinical review: the role of advanced glycation end products in progression and complications of diabetesJ Clin Endocrinol Metab93200811431152
  • C.CeramiH.FoundsI.NichollT.MitsuhashiD.GiordanoS.VanpattenTobacco smoke is a source of toxic reactive glycation productsProc Natl Acad Sci USA9419971391513920
  • T.GoldbergW.CaiM.PeppaV.DardaineB.S.BaligaJ.UribarriAdvanced glycoxidation end products in commonly consumed foodsJ Am Diet Assoc104200412871291
  • A.M.de AssisD.K.RiegerA.LongoniC.BattuS.RaymundiR.F.da RochaHigh fat and highly thermolyzed fat diets promote insulin resistance and increase DNA damage in ratsExp Biol Med (Maywood)234200912961304
  • E.Diamanti-KandarakisC.PiperiP.KorkolopoulouE.KandarakiG.LevidouA.PapaloisAccumulation of dietary glycotoxins in the reproductive system of normal female ratsJ Mol Med85200714131420
  • N.C.AveryA.J.BaileyThe effects of the Maillard reaction on the physical properties and cell interactions of collagenPathol Biol (Paris)542006387395
  • K.ŠebekovαR.SchinzelH.LingA.SimmG.XiangM.GekleAdvanced glycated albumin impairs protein degradation in the kidney proximal tubular cell line LLC-PK1Cell Mol Biol44199810511060
  • G.LubeckA.PollakReduced susceptibility of non-enzymatically glycosylated glomerular basement membrane to proteinasesRenal Physiol3198048
  • R.BucalaZ.MakitaG.VegaS.GrundyT.KoschinskyA.CeramiModification of low-density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiencyProc Natl Acad Sci USA91199494419445
  • H.StopperN.SchuppA.KlassenK.SebekovaA.HeidlandGenomic damage in chronic renal failure – potential therapeutic interventionsJ Ren Nutr1520058186
  • J.M.BohlenderS.FrankeG.SteinG.WolfAdvanced glycation end products and the kidneyAm J Physiol Renal Physiol2892005F645F659
  • D.SuzukiM.ToyodaN.YamamotoM.MiyauchiM.KatohM.KimuraRelationship between the expression of advanced glycation end-products (AGE) and the receptor for AGE (RAGE) mRNA in diabetic nephropathyIntern Med452006435441
  • A.BierhausD.M.SternP.P.NawrothRAGE in inflammation: a new therapeutic target?Curr Opin Investig Drugs72006985991
  • H.VlassaraAdvanced glycation in health and disease. Role of modern environmentAnn NY Acad Sci10432005452460
  • T.KoschinskyC.J.HeT.MitsuhashiR.BucalaC.LiuC.BuentingOrally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathyProc Natl Acad Sci USA94199764746479
  • J.UribarriM.PeppaW.CaiT.GoldbergM.LuS.BaligaDietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patientsAm J Kidney Dis422003532538
  • A.GugliucciM.BendayanRenal fate of circulating advanced glycation end products (AGEs): evidence for absorption and catabolism of AGE-peptides by renal proximal tubular cellsDiabetologia391996149160
  • A.SaitoT.TakedaK.SatoH.HamaA.TanumaR.KasedaSignificance of proximal tubular metabolism of advanced glycation end products in kidney diseasesAnn NY Acad Sci10432005637643
  • L.J.JensenJ.OstergaardA.FlyvbjergAGE–RAGE and AGE cross-link interaction: important players in the pathogenesis of diabetic kidney diseaseHorm Metab Res37suppl 120052634
  • R.D.SembaL.FerrucciJ.C.FinkK.SunJ.BeckM.DalalAdvanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling womenAm J Kidney Dis5320095158
  • P.StenvinkelJ.J.CarreroJ.AxelssonB.LindholmO.HeimburgerZ.MassyEmerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?Clin J Am Soc Nephrol32008505521
  • I.Z.PawluczykE.K.TanK.P.HarrisRat mesangial cells exhibit sex-specific profibrotic and proinflammatory phenotypesNephrol Dial Transplant24200917531758
  • E.Diamanti-KandarakisC.PiperiA.KalofoutisG.CreatsasIncreased levels of serum advanced glycation end-products in women with polycystic ovary syndromeClin Endocrinol (Oxf)6220053743
  • L.ManneråsS.CajanderA.HolmängZ.SeleskovicT.LystigM.LönnA new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndromeEndocrinology148200737813791
  • M.FassnachtN.SchlenzS.B.SchneiderS.A.WudyB.AllolioW.ArltBeyond adrenal and ovarian androgen generation: increased peripheral 5α-reductase activity in women with polycystic ovary syndromeJ Clin Endocrinol Metab88200327602766
  • M.E.SilfenM.R.DenburgA.M.ManiboR.A.LoboR.JaffeM.FerinEarly endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescentsJ Clin Endocrinol Metab88200346824688
  • J.B.HenryClinical Diagnosis and Management by Laboratory Methodsvol. 11979W.B Saunders CompanyPhiladelphia
  • S.WolfensohnM.LloydHandbook of Laboratory Animal Management and Welfare1994Oxford University PressOxford
  • P.J.van DiestP.van DamS.C.Henzen-LogmansE.BernsM.E.van der BurgJ.GreenA scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative GroupJ Clin Pathol501997801804
  • T.MiyataY.UedaK.HorieM.NangakuS.TanakaC.van Ypersele de StrihouRenal catabolism of AGEs: the fate of pentosidineKidney Int531998416422
  • R.SchinzelG.MünchA.HeidlandK.SebekovaAdvanced glycation end products in end-stage renal disease and their removalNephron872001295303
  • A.BostomHomocysteine: “expensive creatinine” or important modifiable risk factor for arteriosclerotic outcomes in renal transplant recipients?J Am Soc Nephrol112000149151
  • E.D.SchleicherE.WagnerA.G.NerlichIncreased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and agingJ Clin Invest991997457468
  • K.HorieT.MiyataK.MaedaS.MiyataS.SugiyamaH.SakaiImmunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathyJ Clin Invest100199729953004
  • H.VlassaraL.J.StrikerS.TeichbergH.FuhY.M.LiM.SteffesAdvanced glycation end products induce glomerular sclerosis and albuminuria in normal ratsProc Natl Acad Sci USA9119941170411708
  • L.GuS.HagiwaraQ.FanM.TanimotoM.KobataM.YamashitaRole of receptor for advanced glycation end-products and signaling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytesNephrol Dial Transplant212006299313
  • N.TanjiG.S.MarkowitzC.FuT.KislingerA.TaguchiM.PischetsriederExpression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal diseaseJ Am Soc Nephrol11200016561666
  • J.R.LombetS.G.AdlerP.S.AndersonC.C.NastD.R.OlsenR.J.GlassockSex vulnerability in the subtotal nephrectomy model of glomerulosclerosis in the ratJ Lab Clin Med11419896674
  • P.D.MetcalfeJ.A.LeslieM.T.CampbellD.R.MeldrumK.L.HileK.K.MeldrumTestosterone exacerbates obstructive renal injury by stimulating TNF-alpha production and increasing proapoptotic and profibrotic signalingAm J Physiol Endocrinol Metab2942008E435E443
  • G.A.KaysenThe microinflammatory state in uremia: causes and potential consequencesJ Am Soc Nephrol12200115491557
  • J.HimmelfarbP.StenvinkelT.A.IkizlerR.M.HakimThe elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremiaKidney Int62200215241538
  • M.AriciJ.WallsEnd-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?Kidney Int592001407414
  • P.StenvinkelInflammatory and atherosclerotic interactions in the depleted uremic patientBlood Purif1020015361